|
| | Publication Year | Title | Author(s) |
| 1 | 1-Nov-2023 | PD-L1 PET imaging in patients with NSCLC: Preliminary results of the ImmunoPET Phase 0 study. | Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian W; Akhurst, Tim; Roselt, Peter; Sursock, Sandra; Trinh, Jenny; John, Thomas ; Devereux, Lisa; Donnelly, Paul S; Hicks, Rodney J; Scott, Andrew M ; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun ; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacManus, Michael |
| 2 | 7-Aug-2023 | Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study. | Huang, Joanna; Faisal, Wasek; Brand, Margaret; Smith, Shantelle; Alexander, Marliese; Briggs, Lisa; Conron, Matthew; Duffy, Mary; John, Thomas ; Langton, David; Lesage, Jacqueline; MacManus, Michael; Mitchell, Paul L R ; Olesen, Inger; Parente, Phillip; Philip, Jennifer; Samuel, Evangeline; Torres, Javier; Underhill, Craig R; Zalcberg, John R; Harden, Susan; Stirling, Rob |
| 3 | Apr-2023 | LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC. | Alexander, Marliese; Wei, Joe; Parakh, Sagun ; John, Thomas ; Kao, Steven; Nagrial, Adnan; Bowyer, Samantha; Warburton, Lydia; Moore, Melissa; Hughes, Brett G M; Clay, Timothy D; Pavlakis, Nick; Solomon, Benjamin J; Itchins, Malinda |
| 4 | Apr-2023 | Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review. | Rangamuwa, Kanishka; Aloe, Christian; Christie, Michael; Asselin-Labat, Marie-Liesse; Batey, Daniel; Irving, Lou; John, Tom ; Bozinovski, Steven; Leong, Tracy L ; Steinfort, Daniel |
| 5 | 27-Feb-2023 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. | Chmielecki, Juliann; Mok, Tony; Wu, Yi-Long; Han, Ji-Youn; Ahn, Myung-Ju; Ramalingam, Suresh S; John, Thomas ; Okamoto, Isamu; Yang, James Chih-Hsin; Shepherd, Frances A; Bulusu, Krishna C; Laus, Gianluca; Collins, Barbara; Barrett, J Carl; Hartmaier, Ryan J; Papadimitrakopoulou, Vassiliki |
| 6 | 22-Feb-2023 | Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer. | Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A; de Marinis, Filippo; John, Thomas ; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel |
| 7 | 31-Jan-2023 | Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. | Herbst, Roy S; Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vu, Huu Vinh; Lu, Shun; Lee, Kye Young; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Urban, Damien; Huang, Xiangning; Bolanos, Ana; Stachowiak, Marta; Tsuboi, Masahiro |
| 8 | 28-Jan-2023 | First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes. | Reck, Martin; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Cheng, Ying; Sakai, Hiroshi; Paz-Ares, Luis; Lu, Shun; John, Thomas ; Sun, Xiaowu; Moisei, Aniela; Taylor, Fiona; Lawrance, Rachael; Zhang, Xiaoqing; Sylvester, Judi; Yuan, Yong; Blum, Steven I; Penrod, John R; Carbone, David P |
| 9 | Dec-2022 | A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases. | Itchins, Malinda; Ainsworth, Hannah; Alexander, Marliese; Dean, Samantha; Dharmaraj, Devi; Pavlakis, Nick; Clarke, Stephen J; Brown, Chris; Torres, Javier; Saqib, Ayesha; Ladwa, Rahul; O'Byrne, Kenneth; Moore, Melissa; Yip, Po Yee; Solomon, Ben; John, Tom ; Kao, Steven; Mitchell, Paul L R ; Parakh, Sagun |
| 10 | 18-Nov-2022 | ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol. | Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian; Akhurst, Tim; Roselt, Peter; Trinh, Jenny; John, Thomas ; Devereux, Lisa; Donnelly, Paul S; Hicks, Rod; Scott, Andrew M ; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun ; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacManus, Michael |
| 11 | 1-Jun-2022 | Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial. | Majem, Margarita; Goldman, Jonathan W; John, Thomas ; Grohe, Christian; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu Vinh; Lu, Shun; Li, Shanqing; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Atagi, Shinji; Zeng, Lingmin; Kulkarni, Dakshayini; Medic, Nenad; Tsuboi, Masahiro; Herbst, Roy S; Wu, Yi-Long |
| 12 | May-2022 | Loss of STING expression is prognostic in non-small cell lung cancer. | Lohinai, Zoltan; Dora, David; Caldwell, Charles; Rivard, Christopher J; Suda, Kenichi; Yu, Hui; Rivalland, Gareth; Ellison, Kim; Rozeboom, Leslie; Dziadziuszko, Rafal; Mitchell, Paul L R ; John, Thomas ; Millan, Inigo S; Ren, Shengxiang; Hirsch, Fred R |
| 13 | 29-Apr-2022 | Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC. | Drilon, Alexander; Chiu, Chao-Hua; Fan, Yun; Cho, Byoung Chul; Lu, Shun; Ahn, Myung-Ju; Krebs, Matthew G; Liu, Stephen V; John, Thomas ; Otterson, Gregory A; Tan, Daniel S W; Patil, Tejas; Dziadziuszko, Rafal; Massarelli, Erminia; Seto, Takashi; Doebele, Robert C; Pitcher, Bethany; Kurtsikidze, Nino; Heinzmann, Sebastian; Siena, Salvatore |
| 14 | 1-Apr-2022 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors. | Demetri, George D; De Braud, Filippo; Drilon, Alexander; Siena, Salvatore; Patel, Manish R; Cho, Byoung Chul; Liu, Stephen V; Ahn, Myung-Ju; Chiu, Chao-Hua; Lin, Jessica J; Goto, Koichi; Lee, Jeeyun; Bazhenova, Lyudmila; John, Thomas ; Fakih, Marwan; Chawla, Sant P; Dziadziuszko, Rafal; Seto, Takashi; Heinzmann, Sebastian; Pitcher, Bethany; Chen, David; Wilson, Timothy R; Rolfo, Christian |
| 15 | Apr-2022 | First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA. | John, Thomas ; Sakai, Hiroshi; Ikeda, Satoshi; Cheng, Ying; Kasahara, Kazuo; Sato, Yuki; Nakahara, Yoshiro; Takeda, Masayuki; Kaneda, Hiroyasu; Zhang, Helong; Maemondo, Makoto; Minato, Koichi; Hisada, Takeshi; Misumi, Yuki; Satouchi, Miyako; Hotta, Katsuyuki; Li, Ang; Oukessou, Abderrahim; Lu, Shun |
| 16 | 2022 | Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC. | Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Kim, Sang-We; Kato, Terufumi; Laktionov, Konstantin; Vu, Huu Vinh; Wang, Zhijie; Lu, Shun; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Atasoy, Ajlan; Herbst, Roy S; Tsuboi, Masahiro |
| 17 | 2-Dec-2021 | Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]. | Reck, M; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, P-J; De Marchi, P; Martin, C; Pérol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, D P; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, Thomas |
| 18 | 1-Dec-2021 | A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer. | Wu, Yi-Long; Tsuboi, Masahiro; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S |
| 19 | 1-Oct-2021 | First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update. | Reck, M; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, P-J; De Marchi, P; Martin, C; Pérol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, D P; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, Thomas |
| 20 | 8-Sep-2021 | Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants. | Murali, Krithika; Dwarte, Tanya M; Nikfarjam, Mehrdad ; Tucker, Katherine M; Vaughan, Rhys B ; Efthymiou, Marios ; Collins, Allison L ; Spigelman, Allan D; Salmon, Lucinda ; Johns, Amber L; Williams, David B; Delatycki, Martin B ; John, Thomas ; Stoita, Alina |
Loading...
2
0
20
0
false
0000-0003-3399-5342